EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PTCT: Ptc Therapeutics

25 Jun 26 09:32
LAST:

84.70

CHANGE:
 0.35		OPEN:
83.14		HIGH:
85.14		ASK:
15.45		VOLUME:
16.3K
CHG(%):
0.41		PREV:
84.35		LOW:
83.14		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Jun 2683.1485.1483.1484.7016.3K
24 Jun 2682.9985.1581.8184.413.32M
23 Jun 2681.0583.0580.3082.132.31M
22 Jun 2680.0081.7179.5180.962.41M
18 Jun 2679.5880.0078.1078.982.87M
17 Jun 2675.5679.6074.8778.533.18M
16 Jun 2675.4076.9572.0473.276.04M
15 Jun 2672.0377.1371.8076.773.59M
12 Jun 2674.7175.9374.3675.141.07M
11 Jun 2673.4075.5172.6674.712.25M

PROFILE

Name:Ptc Therapeutics
About:PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:500 Warren Corporate Center Drive, Warren, NJ, United States, 07059
Website:https://www.ptcbio.com
CUSIP:69366J200
CIK:0001070081
ISIN:US69366J2006
FIGI:BBG000QT15P7
LEI:549300UJLWOIWFDGB318

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:8.05 
Forward P/E:28.42 
PEG Ratio:-0.27 
Price to Sales:3.07 
Price to Book:-27.41 
Profit Margin:0.36 
Operating Margin:-0.19 
Return on Assets:0.24 
Return on Equity:0.33 
EPS Ratio:8.58 
Revenue:1.765B 
EBITDA:35.36M 
Shares:82.77M 
Market Cap:7.011B 

TECHNICAL INDICATORS

MA5:82.282.9%
MA10:78.987.2%
MA20:75.2512.6%
MA50:72.0117.6%
MA100:70.3020.5%
MA200:70.8119.6%
STO9:97.98 
STO14:98.32 
RSI14:82.24 
MTM14:13.94
ROC14:0.20 
ATR:3.18 
Week High:85.150.5%
Week Low:78.108.5%
Month High:85.150.5%
Month Low:67.1719.6%
Year High:87.503.3%
Year Low:43.1896.2%
Volatility:6.65